Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Renuka, Khurana"'
Publikováno v:
Sexually Transmitted Diseases. 50:298-303
Autor:
Gwenan M. Knight, Nila J. Dharan, Gregory J. Fox, Natalie Stennis, Alice Zwerling, Renuka Khurana, David W. Dowdy
Publikováno v:
International Journal of Infectious Diseases, Vol 42, Iss C, Pp 17-23 (2016)
The dominant approach to decision-making in public health policy for infectious diseases relies heavily on expert opinion, which often applies empirical evidence to policy questions in a manner that is neither systematic nor transparent. Although sys
Externí odkaz:
https://doaj.org/article/2cd8082b136a4e089eff18bea5201775
Autor:
Samuel B, Holzman, Allison, Perry, Paul, Saleeb, Alexandra, Pyan, Chris, Keh, Katya, Salcedo, Masahiro, Narita, Amina, Ahmed, Thaddeus L, Miller, April C, Pettit, Renuka, Khurana, Matthew, Whipple, Dolly, Katz, Angela, Largen, Amy, Krueger, Maunank, Shah
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 75(10)
Tuberculosis (TB) elimination within the United States will require scaling up TB preventive services. Many public health departments offer care for latent tuberculosis infection (LTBI), although gaps in the LTBI care cascade are not well quantified.
Publikováno v:
Canadian Journal of Gastroenterology, Vol 19, Iss 7, Pp 441-445 (2005)
Previous consensus statements have recommended one- to two-week proton pump inhibitor (PPI)-based triple therapies with clarithromycin and either amoxicillin or metronidazole as first-line treatments for children with Helicobacter pylori infection. T
Externí odkaz:
https://doaj.org/article/fc3a1c7b01184cda94f78a1899cbed9d
Autor:
Christine S Ho, Pei-Jean I Feng, Masahiro Narita, Jason E Stout, Michael Chen, Lisa Pascopella, Richard Garfein, Randall Reves, Dolly J Katz, Jennifer Flood, Julie Higashi, Kathleen Moser, Marisa Moore, Constance Benson, Robert Belknap, Jason E. Stout, Amina Ahmed, Timothy Sterling, April Pettit, Henry M. Blumberg, Alawode Oladele, Michael Lauzardo, Marie N. Seraphin, Richard Brostrom, Renuka Khurana, Wendy Cronin, Susan Dorman, David Horne, Thaddeus Miller
Publikováno v:
Lancet Infect Dis
BACKGROUND: Treatment of latent tuberculosis infection is an important strategy to prevent tuberculosis disease. In the USA, three tests are used to identify latent tuberculosis infection: the tuberculin skin test (TST) and two IFN-γ release assays
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08e933412283cfc14021bf1b6a2b52ce
https://europepmc.org/articles/PMC8712384/
https://europepmc.org/articles/PMC8712384/
Autor:
Rose Punnoose, Katya Salcedo, Dolly J. Katz, Renuka Khurana, James Gaensbauer, Randall Reves, Pei-Jean I. Feng, Amina Ahmed
Publikováno v:
Pediatrics
OBJECTIVES: The tuberculin skin test (TST) has been preferred for screening young children for latent tuberculosis infection (LTBI) because of concerns that interferon-γ release assays (IGRAs) may be less sensitive in this high-risk population. In t
Autor:
Gwenan M. Knight, Renuka Khurana, Alice Zwerling, David W. Dowdy, Gregory J. Fox, Nila J. Dharan, Natalie Stennis
Publikováno v:
International Journal of Infectious Diseases, Vol 42, Iss C, Pp 17-23 (2016)
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
SUMMARY The dominant approach to decision-making in public health policy for infectious diseases relies heavily on expert opinion, which often applies empirical evidence to policy questions in a manner that is neither systematic nor transparent. Alth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fc8f2623c87b5a593d734570eda71c7
https://researchonline.lshtm.ac.uk/id/eprint/2344844/1/nihms745187.PMC4996966.pdf
https://researchonline.lshtm.ac.uk/id/eprint/2344844/1/nihms745187.PMC4996966.pdf
Publikováno v:
Canadian Journal of Gastroenterology, Vol 19, Iss 7, Pp 441-445 (2005)
Previous consensus statements have recommended one- to two-week proton pump inhibitor (PPI)-based triple therapies with clarithromycin and either amoxicillin or metronidazole as first-line treatments for children with Helicobacter pylori infection. T